Loading clinical trials...
Loading clinical trials...
Non Genetic Factors in the Pathogenesis of Inflammatory Bowel Disease in Twins
This study aims to investigate the role of non-genetic factors in the pathogenesis of inflammatory bowel disease.An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease.
Background: The inflammatory bowel diseases (IBD), Crohn's Disease (CD) and Ulcerative Colitis (UC), are debilitating conditions with a complex aetiology. The biggest risk factor for developing IBD is having an affected first degree relative. However when an identical twin is diagnosed with IBD, the other twin goes on to develop the condition in only 20-55% of cases. Recent research suggests the microbiota the ecosystem of bacteria within the gut may trigger disease in susceptible individuals. Another important research area is the epigenome changes to the structure and regulation of our genome which occur throughout our life. It is known that siblings of Crohn's Disease sufferers have a changes to the immune system characteristic of Crohn';s. However it is not known whether these changes are due to genetic similarity or shared environment. Comparison between mono and dizygotic twins elucidates the relative importance of genetic and environmental factors. Primary Objective: An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease. Study Design: Multicentre basic science study involving human participants Planned sample size: 200 data subjects (100 twin pairs) Methodology: A) Identification of twin pairs where one or both have inflammatory bowel disease via: 1. IBD Nixon Twin and Multiplex Registry. 2. Advertising for twin pairs via BSG website and newsletters/patient support groups/social media sites/clinic posters. 3. Identification by study sites B) Obtaining formal written consent C) Collection of blood, stool and urine. D) The following analysis will be carried out: * Epigenetics (blood) DNA extraction and subsequent methylation analysis and bisulphate conversion with 450 Illumina beadchip assay * Functional immunology (blood) - flow cytometry of CD3, CD4 and CD8 cells. (London Twin pairs discordant for Crohn's Disease) * 16S rRNA gene sequencing (stool) - of bacterial DNA * Metabolomic profiling (Urine and stool) - using Nuclear Magnetic Resonance (NMR) and mass spectrometry E) Collection of dietary history information for the previous 72hr period Study Duration: 2 years (single visit).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Chelsea and Westminster Hosptial
London, United Kingdom
Start Date
May 1, 2015
Primary Completion Date
October 1, 2017
Completion Date
October 1, 2017
Last Updated
October 26, 2017
200
ESTIMATED participants
Lead Sponsor
St Stephens Aids Trust
NCT06226883
NCT07271069
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07207200